Teva promises to keep building its OTC business

19 April 2018 - Deborah Wilkes

Archived

Teva Pharmaceutical says it will continue to build its OTC business after the company's PGT Healthcare OTC joint venture with Procter & Gamble ends on 1 July 2018.

Click tags below for more information on topics:

Teva

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: